SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-16-000009
Filing Date
2016-12-09
Accepted
2016-12-09 17:29:30
Documents
46
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myovant10qq22016.htm 10-Q 732203
2 EXHIBIT 31.1 myovantex311q22016.htm EX-31.1 9448
3 EXHIBIT 31.2 myovantex312q22016.htm EX-31.2 9566
4 EXHIBIT 32.1 myovantex321q22016.htm EX-32.1 5554
5 EXHIBIT 32.2 myovantex322q22016.htm EX-32.2 5506
  Complete submission text file 0001679082-16-000009.txt   2764359

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20150930.xml EX-101.INS 339685
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20150930.xsd EX-101.SCH 24370
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20150930_cal.xml EX-101.CAL 34011
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20150930_def.xml EX-101.DEF 121507
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20150930_lab.xml EX-101.LAB 341985
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20150930_pre.xml EX-101.PRE 197086
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 162044845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences